Liberty One Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.09M Buy
50,865
+2,041
+4% +$286K 0.73% 31
2025
Q4
$5.99M Sell
48,824
-70,571
-59% -$8.58M 0.77% 27
2025
Q3
$13.3M Buy
119,395
+50,492
+73% +$5.74M 0.75% 26
2025
Q2
$7.64M Sell
68,903
-10,050
-13% -$1.07M 0.77% 26
2025
Q1
$8.85M Sell
78,953
-15,009
-16% -$1.55M 0.9% 25
2024
Q4
$8.68M Sell
93,962
-7,350
-7% -$662K 0.94% 25
2024
Q3
$8.49M Sell
101,312
-2,762
-3% -$211K 0.87% 26
2024
Q2
$7.14M Buy
104,074
+2,335
+2% +$156K 0.8% 29
2024
Q1
$7.45M Sell
101,739
-55
-0.1% -$4.23K 0.84% 27
2023
Q4
$8.25M Buy
101,794
+1,592
+2% +$124K 1.02% 26
2023
Q3
$7.51M Sell
100,202
-40,863
-29% -$3.14M 1.09% 24
2023
Q2
$10.9M Buy
141,065
+2,112
+2% +$168K 1.41% 27
2023
Q1
$11.5M Sell
138,953
-33,672
-20% -$2.79M 1.57% 27
2022
Q4
$14.8M Sell
172,625
-11,162
-6% -$884K 2.13% 21
2022
Q3
$11.3M Buy
183,787
+14,810
+9% +$934K 1.87% 22
2022
Q2
$11.6M Sell
168,977
-7,229
-4% -$448K 1.98% 23
2022
Q1
$10.5M Buy
176,206
+4,126
+2% +$264K 1.59% 26
2021
Q4
$12.5M Buy
172,080
+4,253
+3% +$293K 1.88% 24
2021
Q3
$11.7M Sell
167,827
-1,150
-0.7% -$80.8K 2% 22
2021
Q2
$11.6M Buy
168,977
+6,306
+4% +$421K 1.97% 23
2021
Q1
$10.5M Buy
+162,671
New +$10.5M 1.87% 25

Other funds holding GILD

Liberty One Investment Management's GILD Position: Q1 2026 in Review

Liberty One Investment Management increased its Gilead Sciences (GILD) stake by 4.2% in Q1 2026, buying an estimated $286K and bringing the position to 50,865 shares worth $7.09M. The position accounts for 0.73% of the portfolio, ranked #31.

Liberty One Investment Management first reported a position in GILD in Q1 2021 and has held it in 21 quarters since. The position peaked at $14.8M in Q4 2022. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Liberty One Investment Management held 50,865 shares of Gilead Sciences worth $7.09M as of Q1 2026.
  • Liberty One Investment Management bought 2,041 Gilead Sciences shares in Q1 2026, an estimated $286K.
  • Gilead Sciences made up 0.73% of Liberty One Investment Management's portfolio in Q1 2026, its #31 holding.
  • Liberty One Investment Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 21 quarters since.
  • Liberty One Investment Management's Gilead Sciences position peaked at $14.8M in Q4 2022.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Liberty One Investment Management's 13F filing for Q1 2026, filed 14 May 2026.